- Report
- March 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
€4328EUR$4,850USD£3,816GBP
- Report
- August 2025
- 154 Pages
Global
From €3524EUR$3,950USD£3,108GBP
- Report
- June 2025
- 172 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- June 2025
- 141 Pages
Global
From €3524EUR$3,950USD£3,108GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2489EUR$2,789USD£2,194GBP
- Report
- July 2025
- 350 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- June 2025
- 400 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- June 2025
- 400 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- June 2025
- 400 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- April 2025
- 81 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- March 2025
- 115 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- March 2025
- 119 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- September 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- September 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- September 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- June 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
€4328EUR$4,850USD£3,816GBP
- Report
- March 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
€4328EUR$4,850USD£3,816GBP
- Report
- November 2024
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
€4328EUR$4,850USD£3,816GBP
- Directory
- November 2025
Global
From €3524EUR$3,950USD£3,108GBP
- Report
- September 2025
- 135 Pages
Global
From €3678EUR$4,123USD£3,243GBP
€4328EUR$4,850USD£3,816GBP

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient.
Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more